Stress and inflammation: A biobehavioral approach for nursing research

Western Journal of Nursing Research

Volumn 32, Issue 6, 2010, Pages 730-760

  Kang, Duck Hee ^a   Rice, Marti ^b   Park, Na Jin ^b   Turner Henson, Anne ^b   Downs, Charles ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

biobehavioral research; health; inflammation; stress

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; HUMAN; INFLAMMATION; NURSING RESEARCH; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS;

BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; NURSING RESEARCH; STRESS, PHYSIOLOGICAL;

EID: 77956455651     PISSN: 01939459     EISSN: 15528456     Source Type: Journal    
DOI: 10.1177/0193945909356556     Document Type: Article

References (136)

1. Ader, R., Felten, D.L., & Cohen, N. (2001). Psychoneuroimmunology (3rd ed.). San Diego, CA: Academic Press.
2. Agarwal, S.K., & Marshall, G.D., Jr. (2001). Stress effects on immunity and its application to clinical immunology. Clinical and Experimental Allergy, 31, 25-31.
3. Al Murri, A.M., Bartlett, J.M.S., Canney, P.A., Doughty, J.C., Wilson, C., & McMillan, D.C. (2006). Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. British Journal of Cancer, 94, 227-230.
4. American Cancer Society. (2009). Cancer facts & figures 2009. Atlanta, GA: Author.
5. American Heart Association. (2009). Heart disease and stroke statistics-2009 update. Dallas, TX: Author.
6. Andenaes, R., & Kalfoss, M.H. (2004). Psychological distress in hospitalized patients with chronic obstructive pulmonary disease. European Journal of Epidemiology, 19, 851-859.
7. Antoni, M.H., Lutgendorf, S.K., Cole, S.W., Dhabhar, F.S., Sephton, S.E., McDonald, P.G.,et al.(2006). The influence of bio-behavioural factors on tumor biology: Pathways and mechanisms. Nature Reviews Cancer, 6, 240-248.
8. Augusti, A.G.N., Noguera, A., Sauleda, J., Sala, E., Pons, J., & Busquets, X. (2003). Systemic effects of chronic obstructive pulmonary disease. European Respiratory Journal, 21, 347-360.
9. Bachelot, T., Ray-Coquard, I., Menetrier-Caux, C., Rastkha, M., Duc, A., & Blay, J.-Y. (2003). Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. British Journal of Cancer, 88, 1721-1726.
10. Baniyash, M. (2006). Chronic inflammation, immunosuppression and cancer: New insights and outlook. Seminars in Cancer Biology, 16, 80-88.
11. Barnes, V., Treiber, F., Davis, H., Kelley, T., & Strong, W. (1998). Central adiposity and hemodynamic functioning at rest and during stress in adolescents. International Journal of Obesity, 22, 1079-1083.
12. Ben-Baruch, A. (2006). Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators. Seminars in Cancer Biology, 16, 38-52.
13. Berenson, G., Srinivasan, S., Bao, W., Newman, W., Tracy, R., & Wattigney, W. (1998). Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. New England Journal of Medicine, 338, 1650-1656.
14. Biomarkers Definitions Working Group. (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clinical Pharmacology & Therapeutics, 69, 89-95.
15. Bishop, M. (2005). Quality of life and psychosocial adaptation to chronic illness and disability. Rehabilitation Counseling Bulletin, 48, 219-231.
16. Black, P.H. (2003). The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain, Behavior, and Immunity, 17, 350-364.
17. Black, P.H., & Garbutt, L.D. (2002). Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research, 52, 1-23.
18. Blake, C., Rifai, N., Buring, J., & Ridker, P. (2003). Blood pressure, C-reactive protein and risk of future cardiovascular events. Circulation, 108, 2993-2999.
19. Bower, J.E., Ganz, P.A., Aziz, N., Olmstead, R., Irwin, M.R., & Cole, S.W. (2007). Inflammatory responses to psychological stress in fatigued breast cancer survivors: Relationship to glucocorticoids. Brain, Behavior, and Immunity, 21, 251-258.
20. Bozcuk, H., Uslu, G., Samur, M., Yildiz, M., Ozben, T., Ozdogan, M.,et al.(2004). Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. Cytokine, 27, 58-65.
21. Carroll, D., Ring, C., Hunt, K., Ford, G., & Macintyre, S. (2003). Blood pressure reactions to stress and the prediction of future pressure: Effects of sex, age, and socioeconomic position. Psychosomatic Medicine, 65, 1058-1064.
22. Casadevall, C., Coronell, C., Ramirez-Sarmiento, A.L., Martinez-Llorens, J., Barreiro, E., Orozco-Levi, M.,et al.(2007). Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients. European Respiratory Journal, 30, 605-607.
23. Chrousos, G.P. (2000). Stress, chronic inflammation, and emotional and physical well-being: Concurrent effects and chronic sequelae. Journal of Allergy & Clinical Immunology, 106(Suppl. 5), S275-S291.
24. Chrousos, G.P., & Gold, P.W. (1992). The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. Journal of the American Medical Association, 267, 1244-1252.
25. Chung, K.F. (2001). Cytokines in chronic obstructive pulmonary disease. European Respiratory Journal, 18(Suppl. 34), 50s-59s.
26. Cohen, S., Janicki-Deverts, D., & Miller, G.E. (2007). Psychological stress and disease. Journal of the American Medical Association, 298, 1685-1687.
27. Coker, A.L., Bond, S., Madeleine, M.M., Luchok, K., & Pirisi, L. (2003). Psychosocial stress and cervical neoplasia risk. Psychosomatic Medicine, 65, 644-651.
28. Costanzo, E.S., Lutgendorf, S.K., Sood, A.K., Anderson, B., Sorosky, J., & Lubaroff, D.M. (2005). Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer, 104, 305-313.
29. Coussens, L.M., & Werb, Z. (2002). Inflammation and cancer. Nature, 420, 860-867.
30. Crowther, M. (2005). Pathogenesis of atherosclerosis. Hematology: American Society of Hematology Education Program, 436-441.
31. Dahl, M., Vestbo, J., Lange, P., Bojesen, S.E., Tybjaerg-Hansen, A., & Nordestgaard, B.G. (2007). C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 175, 250-255.
32. Dalton, S.O., Mellemkjaer, L., Olsen, J.H., Mortensen, P.B., & Johansen, C. (2002). Depression and cancer risk: A register-based study of patients hospitalized with affective disorders, Denmark, 1969-1993. American Journal of Epidemiology, 155, 1088-1095.
33. Danesh, J., Wheeler, J., Hirshfield, G., Eda, S., Eiriksdottir, G., Rumley, A.,et al.(2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine, 350, 1387-1397.
34. de Godoy, I., Donahoe, M., Calhoun, W.J., Mancino, J., & Rogers, R.M. (1996). Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. American Journal of Respiratory and Critical Care Medicine, 153, 633-637.
35. Delgado, C. (2007). Sense of coherence, spirituality, stress and quality of life in chronic illness. Journal of Nursing Scholarship, 39, 229-234.
36. Eid, A.A., Jonescu, A.A., Nixon, L.S., Lewis-Jenkins, V., Matthews, S.B., Griffiths, T.L.,et al.(2001). Inflammatory response and body composition in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 164, 1414-1418.
37. Ellins, E., Halcox, J., Donald, A., Field, B., Brydon, L., Deanfield, J.,et al.(2008). Arterial stiffness and inflammatory response to psychophysiological stress. Brain, Behavior, and Immunity, 22, 941-948.
38. Epel, E.S., Blackburn, E.H., Lin, J., Dunbhar, F.S., Adler, N.E., Morrow, J.D.,et al.(2004). Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Sciences of the United States of America, 101, 17312-17315.
39. Everson-Rose, S., & Lewis, T. (2005). Psychosocial factors and cardiovascular diseases. Annual Review of Public Health, 26, 469-500.
40. Feghali, C.A., & Wright, T.M. (1997). Cytokines in acute and chronic inflammation. Frontiers in Bioscience, 2, d12-d26.
41. Gallo, J.J., Armenian, H.K., Ford, D.E., Eaton, W.W., & Khachaturian, A.S. (2000). Major depression and cancer: The 13-year follow-up of the Baltimore epidemiologic catchment area sample (United States). Cancer Causes and Control, 11, 751-758.
42. Gan, W.Q., Man, S.F.P., Senthilselvan, A., & Sin, D.D. (2004). Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and meta-analysis. Thorax, 59, 574-580.
43. Gidron, Y., & Ronson, A. (2008). Psychosocial factors, biological mediators, and cancer prognosis: A new look at an old story. Current Opinion in Oncology, 20, 386-392.
44. Goshen, I., & Yirmiya, R. (2009). Interleukin-1 (IL-1): A central regulator of stress responses. Frontiers in Neuroendocrinology, 30, 30-45.
45. Goswami, B., Rajappa, M., Sharma, M., & Sharma, A. (2008). Inflammation: Its role and interplay in the development of cancer, with special focus on gynecological malignancies. International Journal of Gynecological Cancer, 18, 591-599.
46. Grady, P.A. (2006). Biobehavioral research at NINR and NIH. Nursing Outlook, 54, 300-302.
47. Greenberger, P.A., Yucha, C.B., Janson, S., & Huss, K. (2007). Using rare diseases as models for biobehavioral research: Allergic bronchopulmonary aspergillosis. Allergy and Asthma Proceedings, 28, 489-496.
48. Hamer, M., Molloy, G., & Stamatakis, E. (2008). Psychological distress as a risk factor for cardiovascular events: Pathophysiological and behavioral mechanisms. Journal of the American College of Cardiology, 52, 2156-2162.
49. Hanahan, D., & Weinberg, R.A. (2000). The hallmarks of cancer. Cell, 100, 57-70.
50. Hanneke, A.C., van Helvoort, Y.F., Heijdra, R.C., de Boer, A.S., Thijs, H.M.H., & Dekhuijzen, P.N.R. (2007). Six-minute walking induced systemic inflammation and oxidative stress in muscle wastes COPD patients. Chest, 131, 439-445.
51. Heikkila, K., Ebrahim, S., & Lawlor, D.A. (2007). A systematic review of the association between circulating concentrations of C-reactive protein and cancer. Journal of Epidemiology and Community Health, 61, 824-833.
52. Hjerl, K., Andersen, E.W., Keiding, N., Sawitz, A., Olsen, J.H., Mortensen, P.B.,et al.(1999). Breast cancer risk among women with psychiatric admission with affective or neurotic disorders: A nationwide cohort study in Denmark. British Journal of Cancer, 81, 907-911.
53. Howren, M.B., Lamkin, D.M., & Suls, J. (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine, 71, 171-186.
54. Hurst, J.R., Donaldson, G.C., Perera, W.R., Wilkinson, T.M., Bilello, J.A., Hagan, G.W.,et al.(2006). Use of a plasma biomarker at exacerbation of chronic obstructive pulmonary disease. American Journal of Critical Care Medicine, 174, 867-874.
55. Hutchinson, W.L., Koenig, W., Frohlich, M., Sund, M., Lowe, G.D., & Pepys, M.B. (2000). Immunoradiometric assay of circulating C-reactive protein: Age-related values in the adult general population. Clinical Chemistry, 46, 934-938.
56. Il'yasova, D., Colbert, L.H., Harris, T.B., Newman, A.B., Bauer, D.C., Satterfield, S.,et al.(2005). Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiology, Biomarkers & Prevention, 14, 2413-2418.
57. Jacobs, J.R., & Bovasso, G.B. (2000). Early and chronic stress and their relation to breast cancer. Psychological Medicine, 30, 669-678.
58. Jarvisalo, M., Harmoinen, A., Hakanen, M., Paakkunainen, U., Viikari, J., Hartiala, J.,et al.(2002). Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 1323-1328.
59. Jehn, C.F., Kuehnhardt, D., Bartholomae, A., Pfeiffer, S., Krebs, M., Regierer, A.C.,et al.(2006). Biomarkers of depression in cancer patients. Cancer, 107, 2723-2729.
60. Johnson, P.M., Vogt, S.K., Burney, M.W., & Muglia, L.J. (2002). COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production. American Journal of Physiology-Endocrinology and Metabolism, 282, E650-E656.
61. Jorgensen, N.R., & Schwarz, P. (2008). Osteoporosis in chronic obstructive pulmonary disease patients. Current Opinion in Pulmonary Medicine, 14, 122-127.
62. Karadag, F., Kirdar, S., Karul, A.B., & Ceylan, E. (2008). The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. European Journal of Internal Medicine, 19, 104-108.
63. Kemeny, M.E., & Schedlowski, M. (2007). Understanding the interaction between psychological stress and immune-related disease: A stepwise progression. Brain, Behavior, and Immunity, 21, 1009-1018.
64. Kiecolt-Glaser, J.K., Preacher, K.J., MacCallum, R.C., Atkinson, C., Malarkey, W.B., & Glaser, R. (2003). Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proceedings of the National Academy of Sciences of the USA, 100, 9090-9095.
65. Kolter, D.P. (2000). Cachexia. Annals of Internal Medicine, 133, 622-634.
66. Kornitzer, M., deSmet, P., Sans, S., Dramaix, M., Boulenguez, C., DeBacker, G.,et al.(2006). Job stress and major coronary events: Results from the Job Stress, Absenteeism and Coronary Heart Disease in Europe study. European Journal of Cardiovascular Prevention and Rehabilitation, 13, 695-704.
67. Koutsokera, A., Kiropoulos, T.S., Nikoulis, D.J., Daniil, Z., Tsolaki, V., Tanou, K.,et al.(2009). Clinical, functional and biochemical changes during recovery from COPD exacerbations. Respiratory Medicine, 103, 919-926.
68. Kushner, I., Rzewnicki, D., & Samols, D. (2006). What does minor elevation of C-reactive protein signify? American Journal of Medicine, 119, 166e117-166e128.
69. Lande, M., Carson, N., Roy, J., & Meagher, C. (2006). Effects of childhood primary hypertension on carotid intima media thickness: A matched control study. Hypertension, 48, 40-44.
70. Lande, M., Pearson, T., Vermilion, R., Auinger, P., & Fenandez, I. (2008). Elevated blood pressure, race/ethnicity, and C-reactive protein levels in children and adolescents. Pediatrics, 122, 1252-1257.
71. Laurin, C., Lavoie, K.M., Bacon, S.L., Dupuis, G. Lacoste, G., Cartier, A.,et al.(2007). Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest, 132, 148-155.
72. Lazarus, R.S., & Folkman, S. (1984). Stress, appraisal, and coping. New York: Springer.
73. LeResche, L., & Dworkin, S.F. (2002). The role of stress in inflammatory disease, including periodontal disease: Review of concepts and current findings. Periodontology, 30, 91-103.
74. Lin, W.W., & Karin, M. (2007). A cytokine-mediated link between innate immunity, inflammation, and cancer. Journal of Clinical Investigation, 117, 1175-1183.
75. Liuzzo, G., Biasucci, L., Gallimore, J., Grillo, R., Rebuzzi, A., Pepys, M.,et al.(1994). The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. New England Journal of Medicine, 331, 417-424.
76. Lutgendorf, S.K., Garand, L., Buckwalter, K.C., Reimer, T.T., Hong, S.-Y., & Lubaroff, D.M. (1999). Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. Journal of Gerontology: Medical Science, 54A, M434-M439.
77. Lutgendorf, S.K., Weinrib, A.Z., Penedo, F., Russell, D., DeGeest, K., Costanzo, E.S.,et al.(2008). Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. Journal of Clinical Oncology, 26, 4820-4827.
78. Marx, J. (2004). Inflammation and cancer: The link grows stronger. Science, 306, 966-968.
79. Masse, R., Pulin, C., Dassa, C., Lambert, J., Belair, S., & Battaglini, A. (1998). Evaluation and validation of a test of psychological distress in a general population in French Quebec. Canadian Journal of Public Health, 89, 183-187.
80. McEwen, B.S. (1998). Protective and damaging effects of stress mediators. New England Journal of Medicine, 338, 171-179.
81. McEwen, B.S. (2003). Interacting mediators of allostasis and allostatic load: Towards an understanding of resilience in aging. Metabolism, 52(10 Suppl. 2), 10-16.
82. McSorley, M.A., Alberg, A.J., Allen, D.S., Alllen, N.E., Brinton, L.A., Dorgan, J.F.,et al.(2007). C-reactive protein concentrations and subsequent ovarian cancer risk. Obstetrics & Gynecology, 109, 933-941.
83. Moody, L., McCormick, K., & Williams, A.R. (1991). Psychophysiologic correlates of quality of life in chronic bronchitis and emphysema. Western Journal of Nursing Research, 13, 336-347.
84. Mullenix, P., Andersen, C., & Starnes, B. (2005). Atherosclerosis as inflammation. Annals of Vascular Surgery, 19, 130-138.
85. Musselman, D.L., Miller, A.H., Porter, M.R., Manatunga, A., Gao, F., Penna, S.,et al.(2001). Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings. American Journal of Psychiatry, 158, 1252-1257.
86. Nazmi, A., & Victora, C.G. (2007). Socioeconomic and racial/ethnic differentials of C-reactive protein levels: A systematic review of population-based studies. BioMedical Central Public Health, 7, 212.
87. Ness, R.B., & Cottreau, C. (1999). Possible role of ovarian epithelial inflammation in ovarian cancer. Journal of the National Cancer Institute, 91, 1459-1467.
88. Nicolson, P., & Anderson, P. (2003). Quality of life, distress and self-esteem: A focus group study of people with chronic bronchitis. British Journal of Health Psychology, 8, 251-270.
89. O'Connor, M.-F., Irwin, M.R., Seldon, J., Kwan, L., & Ganz, P.A. (2007). Pro-inflammatory cytokines and depression in a familial cancer registry. Psycho-Oncology, 16, 499-501.
90. Pauwels, R.A., Buist, A.S., Calverley, P.M., Jenkins, C.R., & Hurd, S.S. (2001). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease Workshop Summary. American Journal of Respiratory and Critical Care Medicine, 163, 1256-1276.
91. Pearson, T., Mensah, G., Hong, Y., & Smith, S. (2004). CDC/AHA Workshop on markers of inflammation and cardiovascular disease: Application to clinical and public health practice: Overview. Circulation, 110, e543-e544.
92. Pembroke, T.P., Rasul, F., Hart, C.L., Smith, G.D., & Stansfeld, S.A. (2006). Psychological distress and chronic obstructive pulmonary disease in Renfrew and Paisley (MIDSPAN) study. Journal of Epidemiology and Community Health, 60, 789-792.
93. Pepys, M.B. (2005). CRP or not CRP? That is the question. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 1091-1094.
94. Pereira, D.B., Antoni, M.H., Danielson, A., Simon, T., Efantis-Potter, J., Carver, C.S.,et al.(2003). Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosomatic Medicine, 65, 427-434.
95. Peruzza, S., Sergi, G., Vianello, A., Pisent, C., Tiozzo, F., Manzan, A.,et al.(2003). Chronic obstructive pulmonary disease (COPD) in elderly subjects: Impact on functional status and quality of life. Respiratory Medicine, 97, 612-617.
96. Polterauer, S., Grimm, C., Tempfer, C., Sliutz, G., Speiser, P., Reinthaller, A.,et al.(2007). C-reactive protein is a prognostic parameter in patients with cervical cancer. Gynecologic Oncology, 107, 114-117.
97. Raisz, L.G. (1999). Physiology and pathophysiology of bone remodeling. Clinical Chemistry, 45, 1353-1358.
98. Rakoff-Nahoum, S. (2006). Why cancer and inflammation? Yale Journal of Biology and Medicine, 79, 123-130.
99. Reiche, E.M.V., Morimoto, H.K., & Nunes, S.O.V. (2005). Stress and depression-induced immune dysfunction: Implications for the development and progression of cancer. International Review of Psychiatry, 17, 515-527.
100. Reiche, E.M.V., Nunes, S.O.V., & Morimoto, H.K. (2004). Stress, depression, the immune system, and cancer. Lancet Oncology, 5, 617-625.
101. Reiss, S., Peterson, R.A., Gursky, D.M., & McNally, R.J. (1986). Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behaviour Research and Therapy, 24, 1-8.
102. Ribeiro, M., Silva, A., Santos, N., Guazzelle, I., Matos, L., Trombetta, I.,et al.(2005). Diet and exercise training restores blood pressure and vasodilatory responses during physiological maneuvers in obese children. Circulation, 111, 1915-1923.
103. Ridker, P., Cushman, M., Stampfer, M., Tracy, R., & Hennekens, M. (1997). Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine, 336, 973-979.
104. Ridker, P., Cushman, M., Stampfer, M., Tracy, R., & Hennekens, M. (1998). Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation, 97, 425-428.
105. Ridker, P., & the JUPITER Study Group. (2003). Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Rationale and design of the JUPITER trial. Circulation, 208, 2292-2297.
106. Ridker, P., Rifai, N., Rose, L., Buring, J., & Cook, N. (2002). Comparison of C-reactive protein and low-density lipoprotein cholesterol in the prediction of first cardiovascular events. New England Journal of Medicine, 347, 1557-1565.
107. Ridker, P.M. (2003). Application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 107, 363-369.
108. Rohde, G., Borg, I., Wiethege, A., Kauth, M., Jerzinowski, S., Dinh, A.D.,et al.(2008). Inflammatory response to acute viral exacerbations of COPD. Infection, 36, 427-433.
109. Rosengren, A., Hawkens, S., Ounpuu, S., Silwa, K., Zubaid, M., Almahmeed, W.,et al.(2004). Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): Case-control study. Lancet, 364(9438), 953-962.
110. Ross, R. (1999). Atherosclerosis: An inflammatory disease. New England Journal of Medicine, 340, 115-126.
111. Rozanski, A., Blumenthal, J., & Kaplan, J. (1999). Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 99, 2192-2217.
112. Salgado, R., Junius, S., Benoy, I., Dam, P.V., Vermeulen, P., Marck, E.V.,et al.(2003). Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. International Journal of Cancer, 103, 642-646.
113. Schlecht, N.F., Schwartzman, K., & Bourbeau, J. (2005). Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease. Chronic Respiratory Disease, 2, 183-191.
114. Schols, A.M., Buurman, W.A., Staal van den Brekel, A.J., Dentener, M.A., & Wouters, E.F. (1996). Evidence for a relation between metabolic derangements and increased levels of inflammatory markers in a subgroup of patients with chronic obstructive pulmonary disease. Thorax, 51, 819-824.
115. Segerstrom, S.C., & Miller, G.E. (2004). Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychological Bulletin, 130, 601-630.
116. Selye, H. (1974). Stress without distress. Philadelphia: Lippincott.
117. Siemes, C., Visser, L.E., Coebergh, J.W., Splinter, T.A.W., Witteman, J.C., Uitterlinden, A.G.,et al.(2006). C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: The Rotterdam Study. Journal of Clinical Oncology, 24, 5216-5222.
118. Sjowall, C., & Wettero, J. (2007). Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins. Clinica Chimica Acta, 378, 13-23.
119. Smith, J.S., Herrero, R., Bosetti, C., Muñoz, N., Bosch, F.X., Eluf-Neto, J.,et al.(2002). Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. Journal of the National Cancer Institute, 94, 1604-1613.
120. Steptoe, A., Hamer, M., & Chida, Y. (2007). The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis. Brain, Behavior, and Immunity, 21, 901-912.
121. Tartour, E., Gey, A., Sastre-Garau, X., Pannetier, C., Mosseri, V., Kourilsky, P.,et al.(1994). Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: Evidence for enhanced interleukin 6 gene expression in invasive carcinoma. Cancer Research, 54, 6243-6248.
122. Tjiong, M.Y., van der Vange, N., ten Kate, F.J., Tjong, A.H.S.P., ter Schegget, J., Burger, M.P.,et al.(1999). Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. Gynecologic Oncology, 73, 285-291.
123. Trichopoulos, D., Psaltopoulou, T., Orfanos, P., Trichopoulou, A., & Boffetta, P. (2006). Plasma C-reactive protein and risk of cancer: A prospective study from Greece. Cancer Epidemiology, Biomarkers & Prevention, 15, 381-384.
124. Tsilidis, K.K., Branchini, C., Guallar, E., Helzlsouer, K.J., Erlinger, T.P., & Platz, E.A. (2008). C-reactive protein and colorectal cancer risk: A systematic review of prospective studies. International Journal of Cancer, 123, 1133-1140.
125. Urboniene, D., Sakalauskas, R., & Sitkauskiene, B. (2008). C-reactive protein levels in patients with chronic obstructive pulmonary disease. Medicina, 44, 833-840.
126. van Durme, Y.M.T.A., Verhamme, K.M.C., Aarnoudse, A., Van Pottleberge, G.R., Hofman, A., Witteman, J.C.M.,et al.(2009). C-reactive protein levels, haplotypes and the risk of incident chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 179(5), 375-382.
127. van Helvoort, H.A., Heijdra, Y.F., Thijs, H.M., Vina, J., Wanten, G.J., & Dekhuijzen, P.N. (2006). Exercise-induced systemic side effects in muscle-wasted patients with COPD. Medicine and Science in Sports and Exercise, 38, 1543-1552.
128. van Snick, J. (1990). Interleukin-6: An overview. Annual Review of Immunology, 8, 253-278.
129. von Kanel, R. (2008). Psychological distress and cardiovascular risk: What are the links? Journal of the American College of Cardiology, 52, 2163-2165.
130. Vernooy, J.H., Kucukaycan, M., Jacobs, J.A., Chavannes, N.H., Buurman, W.A., Dentener, M.A.,et al.(2002). Local and systemic inflammation in patients with chronic obstructive pulmonary disease: Soluble tumor necrosis factor receptors are increased in sputum. American Journal of Respiratory and Critical Care Medicine, 166, 1218-1224.
131. Wagena, E.J., Arrindell, W.A., Wouters, E.F.M., & van Schayck, C.P. (2005). Are patients with COPD psychologically distressed? European Respiratory Journal, 26, 242-248.
132. Wagner, P.D. (2008). Possible mechanisms underlying the development of cachexia in COPD. European Respiratory Journal, 31, 492-501.
133. Wei, L.-H., Kuo, M.-L., Chen, C.-A., Cheng, W.-F., Cheng, S.-P., Hsieh, F.-J.,et al.(2001). Interleukin-6 in cervical cancer: The relationship with vascular endothelial growth factor. Gynecologic Oncology, 82, 49-56.
134. Yasuda, N., Gotoh, K., Minatoguchi, S., Asano, K., Nishigaki, K., Monura, M.,et al.(1998). An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. Respiratory Medicine, 92, 993-999.
135. Zhang, G.J., & Adachi, I. (1999). Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Research, 19, 1427-1432.
136. Zhang, S.M., Lin, J., Cook, N.R., Lee, I.-M., Manson, J.E., Buring, J.E.,et al.(2007). C-reactive protein and risk of breast cancer. Journal of the National Cancer Institute, 99, 890-894.